SCHEMBL3147307

SCHEMBL3147307

O=C(Nc1ccc(Oc2ccc(C(=O)N3CCC(C(=O)N4CCN(Cc5ccc6c(c5)OCO6)CC4)CC3)cc2)nc1)c1ccc(Cl)c(Cl)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.57
KMT2A Q03164 5/20 0.57
PRKAA2 P54646 2/20 0.49
GAA P10253 2/20 0.49
ALDH1A1 P00352 5/20 0.48
HPGD P15428 1/20 0.46
USP2 O75604 1/20 0.46
PKM P14618 1/20 0.46
LMNA P02545 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
MAPK1 P28482 1/20 0.45
MAPT P10636 1/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
ABCB11 O95342 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
ADRA2A P08913 1/20 0.44
CYP2D6 P10635 1/20 0.44
CHRM1 P11229 1/20 0.44
TBXA2R P21731 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3147389 0.90 MEN1 (0.57) MEN1KMT2APRKAA2ALDH1A1HPGD
SCHEMBL3032991 0.88 KMT2A (0.48) MEN1KMT2APRKAA2ALDH1A1HPGD
SCHEMBL3133330 0.88 MEN1 (0.53) MEN1KMT2APRKAA2ALDH1A1HPGD
Hydrochloric Acid SCHEMBL4761834 0.88 MAPK1 (0.58) MEN1KMT2APRKAA2GAAHPGD
Hydrochloric Acid SCHEMBL3267187 0.86 MEN1 (0.53) MEN1KMT2APRKAA2GAAALDH1A1
SCHEMBL3020824 0.85 MEN1 (0.52) MEN1KMT2APRKAA2ALDH1A1HPGD
SCHEMBL3061567 0.84 KMT2A (0.58) MEN1KMT2APRKAA2ALDH1A1HPGD
SCHEMBL3020822 0.83 MEN1 (0.50) MEN1KMT2APRKAA2ALDH1A1HPGD
SCHEMBL3035668 0.83 PRKAA2 (0.58) PRKAA2GAAALDH1A1PKMLMNA
Bromide SCHEMBL3067318 0.83 MEN1 (0.51) MEN1KMT2APRKAA2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1957073-B1 MEDICINAL DRUG OTSUKA PHARMA CO LTD (JP) 2014-04-23 EP disclosed
US-20120238750-A1 AROMATIC COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. 2012-09-20 US disclosed
US-8236826-B2 Diarylether derivatives as antitumor agents OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-08-07 US disclosed
US-8188277-B2 Aromatic compounds for suppressing the generation of collagen OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2012-05-29 US disclosed
US-20100004438-A1 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2010-01-07 US disclosed
EP-1957073-A2 MEDICINAL DRUG OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2008-08-20 EP disclosed
US-20070270422-A1 Aromatic Compounds OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-11-22 US disclosed
WO-2007066784-A2 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-06-14 WO disclosed
EP-1773797-A2 AROMATIC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2007-04-18 EP disclosed
WO-2006014012-A2 AROMATIC COMPOUNDS OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2006-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120238750-A1 AROMATIC COMPOUND CBR1, CBR3, CYP1A1 MEN1 1020/4885KMT2A 984/4885PRKAA2 4793/4885
US-20100004438-A1 DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS ROS1, CBR1, CBR3 MEN1 1851/4885KMT2A 1623/4885PRKAA2 4098/4885
US-20070270422-A1 Aromatic Compounds COL1A1, COL2A1, COL14A1 MEN1 3512/4885KMT2A 2349/4885PRKAA2 4856/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.